These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 4558729

  • 1. [Clinical study of Pervincamine in a general medicine department].
    Vialette G, Argullos J.
    Lyon Med; 1972 Apr 23; 227(8):773-6. PubMed ID: 4558729
    [No Abstract] [Full Text] [Related]

  • 2. [Angiographic study of the action of pervincamine on cerebral circulation].
    Baiano G, Elefante R, Granata F, Graziussi G.
    Acta Neurol (Napoli); 1974 Mar 23; 29(2):185-9. PubMed ID: 4848048
    [No Abstract] [Full Text] [Related]

  • 3. [The pervincamine. Geriatric applications].
    Vincendeau J.
    Bord Med; 1970 Jun 23; 3(6):1719-22. PubMed ID: 5433899
    [No Abstract] [Full Text] [Related]

  • 4. [Trial of using Cavinton in cerebrovascular disorders].
    Shtok VN, Eremeeva SV.
    Klin Med (Mosk); 1982 Oct 23; 60(10):39-42. PubMed ID: 6757560
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical studies on the effect of hexobendine (Ustimon) on cerebral circulatory disorders].
    Prosenz P, Tschabitscher H.
    Wien Klin Wochenschr; 1965 Dec 03; 77(48):953-5. PubMed ID: 5331101
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical, rheoencephalographic and ophthalmodynamographic double-blind studies of the effects of vincamine in the treatment of cerebrovascular diseases].
    Kauchtschischvili G, Nappi G, Bono G.
    Minerva Med; 1974 May 26; 65(40):2296-315. PubMed ID: 4608671
    [No Abstract] [Full Text] [Related]

  • 7. [Mechanism of the therapeutic effect of vincamine in disorders of the cerebral circulation].
    Zhmurkin VP.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968 May 26; 68(9):1322-5. PubMed ID: 4882670
    [No Abstract] [Full Text] [Related]

  • 8. [Use of sermion, Cavinton and trental in patients with cerebrovascular disorders].
    Lebedeva NV, Khrapova EV.
    Sov Med; 1990 May 26; (1):60-3. PubMed ID: 2190329
    [No Abstract] [Full Text] [Related]

  • 9. [Pervincamine in the treatment of the cerebrovascular syndrome in the gerontopsychiatric patients].
    Fidetzis K, Brosteano R, Keller P.
    Med Welt; 1976 Jul 16; 27(29):1412-4. PubMed ID: 785150
    [No Abstract] [Full Text] [Related]

  • 10. [A new treatment of vertigo by cerebral microcirculation regulation and oxygenator action on the sensorial epithelium of vestibule].
    Ardouin P.
    Rev Laryngol Otol Rhinol (Bord); 1971 Jul 16; 92(9):585-92. PubMed ID: 4946050
    [No Abstract] [Full Text] [Related]

  • 11. [Value of the nitroglycerine test in rheoencephalographic examination of patients with cerebrovascular diseases].
    Kukhtevich II, Proskurkina OA.
    Sov Med; 1969 Jul 16; 32(5):3-8. PubMed ID: 4985370
    [No Abstract] [Full Text] [Related]

  • 12. [Strong delayed-action pervincamine in general medicine].
    Warembourg H, Ketelers JY.
    Lille Med; 1975 Apr 16; 20(4):424-7. PubMed ID: 1152596
    [No Abstract] [Full Text] [Related]

  • 13. [Serial angiographic evaluation of the effects of various vasoactive drugs on cerebral circulation in man].
    Bernini FP, Smaltino F.
    Acta Neurol (Napoli); 1974 Mar 16; 29(2):170-84. PubMed ID: 4849693
    [No Abstract] [Full Text] [Related]

  • 14. [Rheographic study of the activity of some vasoactive drugs on peripheral arterial circulation].
    Capitanucci P, Martinelli M, De Gregorio M.
    Minerva Cardioangiol; 1968 Nov 16; 16(11):1074-82. PubMed ID: 5707452
    [No Abstract] [Full Text] [Related]

  • 15. [Determinants estimating cerebral functions after long term therapy with hydergin].
    Herzfeld U, Christian W, Ronge J, Wittgen M.
    Arztl Forsch; 1972 Jun 10; 26(6):215-28. PubMed ID: 4626216
    [No Abstract] [Full Text] [Related]

  • 16. Heparin resistance in relation to hyperlipidemia and hypercoagulability in atherosclerotic diabetics and non-diabetics.
    Higazi AM, el-Ebrashy N, Aly AM, el-Din AS.
    J Egypt Med Assoc; 1972 Jun 10; 55(8):577-94. PubMed ID: 4658037
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical picture and pathogenesis of cerebral vascular disorders in diabetes mellitus].
    Glonti TI, Sikhrualidze GSh.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972 Jun 10; 72(8):1148-53. PubMed ID: 5078315
    [No Abstract] [Full Text] [Related]

  • 18. [Statistical studies on the results of stroke therapy].
    Eichhorn O, Auell KH, Dörfler L.
    Med Klin; 1965 Dec 24; 60(52):2100-4. PubMed ID: 5333324
    [No Abstract] [Full Text] [Related]

  • 19. [The treatment of ischemic cerebral accidents with pervincamine].
    Warot P, Caron JC.
    Lille Med; 1971 Apr 24; 16():S 2:6l4-9. PubMed ID: 5162101
    [No Abstract] [Full Text] [Related]

  • 20. [Cerebral consequences of essential arterial hypertension, in relation to the stage and clinical form of the disease (hemodynamic study)].
    Hărăguş S, Mureşan IG, Vlaicu R, Butnaru M.
    Med Interna (Bucur); 1970 Sep 24; 22(9):1033-44. PubMed ID: 5491372
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.